BGPartner has advised Novo Holdings and LifeArc Ventures; VISCHER advised GlycoEra AG. GlycoEra Ltd, a Swiss biotechnology company specializing in innovative treatments for autoimmune diseases, has...
GlycoEra Secures USD 130 Million in Series B Financing Led by Novo Holdings and LifeArc Ventures
GlycoEra’s Incresing Its Series A Financing Round
Vischer advised GlycoEra AG on the deal. GlycoEra AG has closed CHF 45m (USD 49m) Series A financing round, co-led by re-nowned US and European life...
GlycoEra’s CHF 45 Million Series A Financing Round
Vischer advised GlycoEra AG on the deal. Walder Wyss advised 5AM Ventures, Roche Venture Fund and Sofinnova Partners as lead investors. GlycoEra AG has closed CHF...



























